e-learning
resources
Munich 2006
Tuesday 05.09.2006
Epidemiology, clinical features, malignant pleural diseases, treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
E. Radzikowska, M. Szolkowska, D. Giedronowicz, D. Gawryluk, J. Grudny, J. Zych, K. Roszkowski (Warsaw, Poland)
Source:
Annual Congress 2006 - Epidemiology, clinical features, malignant pleural diseases, treatment
Session:
Epidemiology, clinical features, malignant pleural diseases, treatment
Session type:
Poster Discussion
Number:
4486
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Radzikowska, M. Szolkowska, D. Giedronowicz, D. Gawryluk, J. Grudny, J. Zych, K. Roszkowski (Warsaw, Poland). Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry. Eur Respir J 2006; 28: Suppl. 50, 4486
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001
Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007
Detection of bone metastases in patients with NSCLC
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002
Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 529s
Year: 2004
Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004
The expression and clinical significance of PD-L1
+
CD68
+
macrophages in peripheral blood mononuclear cells of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018
How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept